ARWR
ArrowheadANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ARWR vs peer average
80/100
ARWR vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 5 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ALNY is the first available peer comparator.
Alnylam is the closest RNAi biopharma platform and commercialization peer. It is not a one-for-one indication comp, but it is the best benchmark for scaled RNAi drug development, launch execution, and how investors may value Arrowhead if REDEMPLO, plozasiran, and follow-on RNAi programs mature beyond the first-product stage.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARWR
Arrowhead
ALNY
Alnylam
Grade
A
B
Momentum
86
19
Value
57
58
Sentiment
63
95
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ALNY
ARWR / ALNY
Grade Position
Above peers
ARWR vs. peer average (A vs. C)
80/100
Momentum
86
ARWRValue
57
ALNYSentiment
63
ALNYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARWR
ALNY is the first peer returned for this comparison set.